Mobility Management

  • Home
  • Topics
    • Automotive Mobility
    • Billing / Reimbursement
    • Government / Legislation
    • Home Accessibility
    • Pediatrics
    • Power Chairs
    • Seating & Positioning
    • Ultralightweights
  • News
  • Featured
  • Podcasts
  • Request Media Kit
  • Webinars
  • Subscribe
  • Digital Edition
  • Awards
  • Advertise

Researchers “Reverse” Protein Mutation Linked to ALS

September 23, 2016 by Laurie Watanabe

University of North Carolina School of Medicine researchers studying proteins that mutate and kill neurons in the brain and spinal cord have figured out a way to stabilize the proteins by in essence reversing the mutation.

In the medical journal Structure, UNC School of Medicine researchers said they stabilized those proteins, called SOD1, by mutating them again. Those changes stopped the proteins from forming clumps, which is when they damaged and killed neurons.

Properly functioning SOD1 proteins work in two pairs rather than in clumps of three.

Researchers were able to create a mutation that simulated the addition of a phosphate group to stabilize the proteins. The newly mutated proteins did not harm neurons.

The discovery could be helpful to patients with amyotrophic lateral sclerosis (ALS) related to SOD1 protein mutations, but researchers said learning how to stabilize proteins such as SOD1 could also benefit patients with other forms of ALS.

Related Articles Read More >

Briefly: Probationary Prior Authorization for New Suppliers; AI’s Impact on Healthcare Clients
Featuring the Centers for Medicare & Medicaid Services and Zanda Health.
Carbon 3D-Printing Patent Upheld by European Patent Office
The company’s technology is being used to create customized wheelchair cushions, among other healthcare and consumer products.
Rocky, steep small island in the middle of a blue-gray sea.
Commentary: The Terrible Cost of Keeping People Apart
Disability rights are human rights — and we’re on a slippery slope.
Texas v. Kennedy: Court Removes Community Integration Provisions from HHS Regulations
The district court decision follows June’s Department of Justice notice that called the Olmstead decision “not enforceable.”

GET THE FREE NEWSLETTER

Mobility Management Newsletter

Subscribe to Mobility Management's newsletter for industry & product news, trends and resources. Click here.
podcasts
Mobility Management
  • HME Business
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • Contact Us
  • About Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Mobility Management

  • Home
  • Topics
    • Automotive Mobility
    • Billing / Reimbursement
    • Government / Legislation
    • Home Accessibility
    • Pediatrics
    • Power Chairs
    • Seating & Positioning
    • Ultralightweights
  • News
  • Featured
  • Podcasts
  • Request Media Kit
  • Webinars
  • Subscribe
  • Digital Edition
  • Awards
  • Advertise